Athira Pharma CEO Mark Litton's 2023 pay falls 40% to $2.3M
Athira Pharma reports 2023 executive compensation
By ExecPay News
Published: April 9, 2024
Athira Pharma reported fiscal year 2023 executive compensation information on April 9, 2024.
In 2023, three executives at Athira Pharma received on average a compensation package of $1.6M, a 38% decrease compared to previous year.
Average pay of disclosed executives at Athira Pharma
Mark Litton, Chief Executive Officer, received $2.3M in total, which decreased by 40% compared to 2022. 61% of Litton's compensation, or $1.4M, was in option awards. Litton also received $298K in non-equity incentive plan, $585K in salary, as well as $85 in other compensation.
Andrew Gengos, Chief Financial Officer, received a compensation package of $1.3M. 68% of the compensation package, or $901K, was in option awards.
Hans Moebius, Chief Medical Officer, earned $1.3M in 2023, a 39% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 9, 2024.